NordICC
The Nordic-European Initiative on Colorectal Cancer, the first randomized trial of colonoscopy, which so far failed to find a reduction in colorectal cancer death
As defined in Vinay Prasad on Cancer Screening
Where it comes up · 2
Most important claims · 3 of 3Search all claims for “NordICC” →
- Cancer screening turns healthy people into patients, generating enormous revenue for hospitals and practitioners; when a study like NordICC threatens that revenue, practitioners respond with motivated reasoning to defend the procedure, even though they are good people who believe they are helping.Vinay Prasad on Cancer Screening
- The NordICC randomized trial in Norway, Sweden, and Poland so far failed to find a reduction in colorectal cancer death from colonoscopy; critics note only 40% of those assigned actually got the procedure, but instrumental variable analysis adjusting for 100% compliance still found no significant benefit, even though even one country with 60% compliance also failed to find benefit.Vinay Prasad on Cancer Screening
- The NordICC trial's discouraging all-cause mortality result for colonoscopy is undermined because it was an effectiveness trial (only 40% complied) recommending colonoscopy just once per 10 years, an interval Attia considers far too infrequent given cancers can appear one to two years after a normal colonoscopy.Peter Attia on Lifespan, Healthspan, and Outlive